Detalhe da pesquisa
1.
HER2-targeting antibody-drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study.
Cancer Immunol Immunother
; 72(7): 2309-2318, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36897337
2.
Pralsetinib for the treatment of a RET-positive advanced non-small-cell lung cancer patient harboring both ANK-RET and CCDC6-RET fusions with coronary heart disease: a case report.
Ann Transl Med
; 10(8): 496, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35571397